RYR2 and catecholaminergic polymorphic ventricular tachycardia: In summary, our study provides evidence that the genetic inhibition of mPTP exacerbates RyR2 dysfunction in CPVT by increasing the autonomous activation of CaMKII and subsequent hyperphosphorylation of RyR2.